Browsing by Subject "Fatigue"
Results Per Page
Sort Options
Item Open Access Anti-hypotensive treatment and endothelin blockade synergistically antagonize exercise fatigue in rats under simulated high altitude.(PLoS One, 2014) Radiloff, Daniel; Zhao, Yulin; Boico, Alina; Blueschke, Gert; Palmer, Gregory; Fontanella, Andrew; Dewhirst, Mark; Piantadosi, Claude A; Noveck, Robert; Irwin, David; Hamilton, Karyn; Klitzman, Bruce; Schroeder, ThiesRapid ascent to high altitude causes illness and fatigue, and there is a demand for effective acute treatments to alleviate such effects. We hypothesized that increased oxygen delivery to the tissue using a combination of a hypertensive agent and an endothelin receptor A antagonist drugs would limit exercise-induced fatigue at simulated high altitude. Our data showed that the combination of 0.1 mg/kg ambrisentan with either 20 mg/kg ephedrine or 10 mg/kg methylphenidate significantly improved exercise duration in rats at simulated altitude of 4,267 m, whereas the individual compounds did not. In normoxic, anesthetized rats, ephedrine alone and in combination with ambrisentan increased heart rate, peripheral blood flow, carotid and pulmonary arterial pressures, breathing rate, and vastus lateralis muscle oxygenation, but under inspired hypoxia, only the combination treatment significantly enhanced muscle oxygenation. Our results suggest that sympathomimetic agents combined with endothelin-A receptor blockers offset altitude-induced fatigue in rats by synergistically increasing the delivery rate of oxygen to hypoxic muscle by concomitantly augmenting perfusion pressure and improving capillary conductance in the skeletal muscle. Our findings might therefore serve as a basis to develop an effective treatment to prevent high-altitude illness and fatigue in humans.Item Open Access Assessing the Injury Tolerance of the Human Spine(2017) Schmidt, Allison LindseyChronic and acute back injuries are widespread, affecting people in environments where they are exposed to vibration and repeated shock. These issues have been widely reported among personnel on aircraft and small watercraft; operators of heavy industrial or construction equipment may also experience morbidity associated with cyclic loading. To prevent these types of injuries, an improved understanding is needed of the spine’s tolerance to fatigue injury and of the factors that affect fatigue tolerance.
These types of vibration and shock exposures are addressed by international standards that propose limitations on the length and severity of the accelerations to which an individual is subjected. However, the current standard, ISO 2631-5:2004, provides an imprecise health hazard assessment. In this dissertation, a detailed technical critique is presented to examine the assumptions on which ISO 2631-5:2004 is based. An original analysis of existing data yields an age-based regression of the ultimate strength of lumbar spinal units and demonstrates sources of error in the strength regression in the standard. This dissertation also demonstrates that, contradicting earlier assumptions, the ultimate strength of the spine does not lie on a power-law S-N curve, and fatigue tolerance cannot be extrapolated from ultimate strength tests.
An alternative approach is presented for estimating the injury risk due to repeated loading. Drawing from existing data in the literature, a large dataset of in vitro fatigue tests of lumbar spinal segments was assembled. Using this fatigue data, a survival analysis approach was used to estimate the risk of failure based on several factors. Number of cycles, load amplitude, sex, and age all were significant predictors of bony failure in the spinal column. The parameter described by ISO 2631-5:2004 to quantify repeated loading exposure was modified, and an injury risk model was developed based on this modified parameter which relates risk of vertebral failure to repeated compressive loading. Notably, the effect of sex on fatigue tolerance persisted after normalizing by area, emphasizing the need for men and women to be addressed separately in the creation of injury risk predictions and occupational guidelines.
Posture has also been implicated in altering the injury mechanisms and tolerance to fatigue loading. However, few previous investigations in cyclic loading have addressed non-neutral postures. To assess the influence of dynamic flexion on the fatigue tolerance of the lumbar spine, a series of tests were conducted which combined a cyclic compressive force with a dynamic flexing motion. A study of 17 spinal segments from six young male cadavers was conducted, with tests ranging from 1000 to 500 000 cycles. Of the 17 specimens, 7 failed during testing. These failures were analyzed using a Cox Proportional Hazards model. As in compressive fatigue behavior, significant factors were the magnitude of the applied load and the age of the specimen. However, when the dynamically flexed specimens in these tests were compared to the specimens in the axial fatigue dataset, the flexion condition did not have a detectable effect on fatigue tolerance.
The Hybrid III dummy is a critical tool the assessment of such loading. Although the Hybrid III was originally designed for automotive frontal impact testing, these dummies have since been used to measure exposures and estimate injury risks of a wide variety of scenarios. These scenarios often involve using the dummy under non-standard temperatures or with little recovery interval between tests. Series of tests were conducted on the Hybrid III neck and lumbar components to assess the effects of rest duration intervals and a range of temperatures. Variations in rest duration intervals had little effect on the response of either component. However, both components were extremely sensitive to changes in temperature. For the 50th percentile male HIII neck, the stiffness fell by 18% between 25°C and 37.5°C; at 0°C, the stiffness more than doubled, increasing by 115%. Temperature variation had an even more pronounced effect on the HIII lumbar. Compared to room temperature, the lumbar stiffness at 37.5°C fell by 40%, and at 12.5°C, the stiffness more than doubled, increasing by 115%.
This dissertation has advanced the state of knowledge about the fatigue characteristics of the spine. An injury risk function has been developed that can serve as a tool for health hazard assessment in occupational standards. It has also contributed a fatigue dataset with dynamic flexion. This work will improve the scientific community’s ability to prevent repeated loading injuries. This dissertation has also demonstrated the immense sensitivity to temperature of the Hybrid III spinal components. This finding has major implications for the interpretation of previously published work using the Hybrid III, for the conduct of future research, and for future dummy design.
Item Open Access Co-occurring Fatigue and Lymphatic Pain Incrementally Aggravate Their Negative Effects on Activities of Daily Living, Emotional Distress, and Overall Health of Breast Cancer Patients.(Integrative cancer therapies, 2022-01) Fu, Mei Rosemary; McTernan, Melissa L; Qiu, Jeanna M; Miaskowski, Christine; Conley, Yvette P; Ko, Eunjung; Axelrod, Deborah; Guth, Amber; Somers, Tamara J; Wood, Lisa J; Wang, YaoBackground
Fatigue and lymphatic pain are the most common and debilitating long-term adverse effects of breast cancer treatment. Fatigue and pain independently have negative effects on quality of life, physical functions, and cancer recurrence-free survival. The interactions between fatigue and pain may aggravate their negative effects.Objectives
Examine the effects of co-occurring fatigue and lymphatic pain on activities of daily living (ADLs), emotional distress, and overall health of breast cancer patients.Methods
A cross-sectional and observational design was used to enroll 354 breast cancer patients. Valid and reliable instruments were used to assess fatigue, lymphatic pain, ADLs, emotional distress, and overall health. Descriptive statistics and multivariable regression models were used for data analysis.Results
After controlling for demographic and clinical factors, patients with co-occurring fatigue and lymphatic pain had higher odds of having impaired ADLs (OR = 24.43, CI = [5.44-109.67], P < .001) and emotional distress (OR = 26.52, CI = [9.64-72.90], P < .001) compared to patients with only fatigue and only lymphatic pain. Patients with co-occurring fatigue and lymphatic pain had 179% increase in impaired ADL scores (B = 8.06, CI = [5.54-10.59]) and 211% increase in emotional distress scores (B = 9.17, CI = [5.52-12.83]) compared to those without co-occurring fatigue and lymphatic pain. Patients with co-occurring fatigue and lymphatic pain had a 34% decrease (B = -26.29, CI = [-31.90 to -20.69]) and patients with only fatigue had a 33% decrease in overall health scores (B = -25.74, 95% CI = [-34.14 to -17.33]), indicating poor overall health.Conclusions
Fatigue and lymphatic pain affected 66.4% of breast cancer patients. Findings from this study suggest that co-occurring fatigue and lymphatic pain have negative effects on breast cancer patients' ADLs, emotional distress, and overall health. The synergistic interactions between fatigue and lymphatic pain incrementally aggravated their negative effects on ADLs and emotional distress. Findings of the study highlight the need to evaluate the underlying mechanisms for co-occurring fatigue and lymphatic pain and develop interventions that target both fatigue and lymphatic pain to improve breast cancer patients' the quality of life.Item Open Access Eculizumab improves fatigue in refractory generalized myasthenia gravis.(Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2019-08) Andersen, Henning; Mantegazza, Renato; Wang, Jing Jing; O'Brien, Fanny; Patra, Kaushik; Howard, James F; REGAIN Study GroupPURPOSE:To evaluate the effect of eculizumab on perceived fatigue in patients with anti-acetylcholine receptor antibody-positive, refractory, generalized myasthenia gravis (MG) using the Quality of Life in Neurological Disorders (Neuro-QOL) Fatigue subscale, and to evaluate correlations between improvements in Neuro-QOL Fatigue and other clinical endpoints. METHODS:Neuro-QOL Fatigue, MG Activities of Daily Living (MG-ADL), Quantitative MG (QMG), and the 15-item MG Quality of Life (MG-QOL15) scales were administered during the phase 3, randomized, placebo-controlled REGAIN study (eculizumab, n = 62; placebo, n = 63) and subsequent open-label extension (OLE). Data were analyzed using repeated-measures models. Correlations between changes in Neuro-QOL Fatigue and in MG-ADL, QMG, and MG-QOL15 scores were determined at REGAIN week 26. RESULTS:At REGAIN week 26, eculizumab-treated patients showed significantly greater improvements in Neuro-QOL Fatigue scores than placebo-treated patients (consistent with improvements in MG-ADL, QMG, and MG-QOL15 scores previously reported in REGAIN). Improvements with eculizumab were sustained through OLE week 52. Correlations between Neuro-QOL Fatigue and MG-QOL15, MG-ADL, and QMG scores were strong for eculizumab-treated patients at REGAIN week 26, and strong, moderate, and weak, respectively, for placebo-treated patients. CONCLUSIONS:Compared with placebo, eculizumab was associated with improvements in perceived fatigue that strongly correlated with improvements in MG-specific outcome measures. Trial ID Registration: NCT01997229, NCT02301624.Item Open Access Multiple Co-occurring Symptoms in Patients with Gastrointestinal Cancers(2021) Lin, YufenBackground: Patients with gastrointestinal (GI) cancers experience 10 to 15 co-occurring symptoms during chemotherapy that decrease their functional status, quality of life (QOL), and overall survival. The purposes of this dissertation were to describe symptom experiences and self-management strategies for multiple co-occurring symptoms in patients with gastric cancer; identify the subgroups of patients with GI cancers based on their distinct symptom experience profiles; and determine differences among these subgroups in demographic and clinical characteristics, as well as co-occurring symptoms and QOL outcomes.
Methods: An integrative review, a qualitative study, and three quantitative studies (i.e., one was cross-sectional, two were longitudinal) were used in this dissertation. Twenty-five studies were included and systematically evaluated in the review. Ten participants were interviewed for their symptom experiences and self-management strategies. Patients (n=405) completed questionnaires (e.g., the Memorial Symptom Assessment Scale, the Lee fatigue Scale, the General Sleep Disturbance Scale) six times over two cycles of chemotherapy. Content analysis was used to analyze the qualitative data. Latent class/profile analysis was used to identify the subgroups of patients with distinct symptom profiles. Differences in demographic and clinical characteristics as well as co-occurring symptoms and QOL outcomes among the subgroups were evaluated using parametric and non-parametric analyses.
Results: The most common symptoms were categorized into physical and affective/cognitive domains. Patients reported a large amount of inter-individual variability and dynamic nature in their experiences of multiple co-occurring symptoms. Four symptom self-management strategies were identified: medications for symptoms, information-seeking from the clinician team, lifestyle modifications, and psychosocial and spiritual support. The risk factors for a higher symptom burden included younger age, not being married/partnered, being unemployed, having childcare responsibilities, lack of regular exercise, having a lower functional status, having a higher comorbidity burden, and self-reported diagnosis of depression. Patients with a more severe symptom profile reported higher levels of morning and evening fatigue, sleep disturbance, anxiety, depressive symptoms, and pain, as well as lower levels of attentional function and QOL scores at enrollment.
Conclusions and Implications: This dissertation is the first to identify the subgroups of patients with GI cancers with distinct symptom experience profiles and examine a number of risk factors associated with more severe symptom profiles, as well as describe symptom experiences and self-management strategies for multiple co-occurring symptoms in patients with gastric cancer. Additional research is warranted to explore underlying mechanisms that contribute to the development of multiple co-occurring symptoms during chemotherapy. Clinicians need to assess for common risk factors and associated co-occurring symptoms, as well as initiate personalized symptom management interventions and referrals.
Item Open Access Self-healing Poly(methyl methacrylate) Bone Cement Utilizing Embedded Microencapsulated 2-Octyl Cyanoacrylate Tissue Adhesive(2013) Brochu, AliceExtending the functional lifetime of acrylic poly(methyl methacrylate) (PMMA) bone cement may reduce the number of revision total joint replacement (TJR) surgeries performed each year. We developed a system utilizing an encapsulated water-reactive, FDA-approved tissue adhesive, 2-octyl cyanoacrylate (OCA), as a healing agent to repair microcracks within a bone cement matrix. The proposed research tested the following hypotheses: (1) reactive OCA can be successfully encapsulated and the resulting capsules thoroughly characterized; (2) the static mechanical properties of the PMMA composite can be improved or maintained through inclusion of an optimal wt% of OCA-containing capsules; (3) PMMA containing encapsulated OCA has a prolonged lifetime when compared with a capsule-free PMMA control as measured by the number of cycles to failure; and (4) the addition of capsules to the PMMA does not significantly alter the biocompatibility of the material. Based on the experiments reported herein, the primary conclusions of this dissertation are as follows: (1) functional OCA can be encapsulated within polyurethane spheres and successfully incorporated into PMMA bone cement; (2) lower wt% of capsules maintained the tensile, compressive, fracture toughness, and bending properties of the PMMA; (3) inclusion of 5 wt% of OCA-containing capsules in the matrix increased the number of cycles to failure when compared to unfilled specimens and those filled with OCA-free capsules; and (4) MG63 human osteosarcoma cell proliferation and viability were unchanged following exposure to OCA-containing PMMA when compared with a capsule-free control.
Item Open Access Tensile Fatigue Characterization of High Strength Hydrogels for Soft Tissue Applications(2021) Koshut, William JosephSynthetic cartilage implants have the potential to deeply transform the treatment of articular cartilage degeneration as well as the progression of osteoarthritis in load-bearing applications of various joints in the human body. To reduce patient morbidity and enhance range of motion, surgeons and material scientists alike are looking to synthetic alternatives re-establish articular cartilage function without introducing higher cost and health burdens. These implants are rigorously tested for their compressive and wear properties over longer timeframes, with the first instance of approved human use coming in the 1st metatarsophalangeal (MTP) joint with poly(vinyl alcohol) (PVA) being the predominant polymer in composition. Despite their promise of dissipating stress and providing smooth joint movement, these synthetic cartilage implants are not well-studied for their tensile fatigue properties which are extremely critical to in vivo performance and implant survival. As a synthetic substitute to match the properties of cartilage in human beings, hydrogels are extensively researched due to their potential biocompatibility. This research describes work dedicated to the advanced mechanical study of synthetic hydrogel systems for cartilage-based applications. The materials of interest are designed to have enhanced monotonic tensile properties for supplementary investigation via tensile fatigue testing. Superior mechanical behavior was achieved through the use of bio-friendly additives, freezing-thawing cyclic processing, and fiber reinforcement. Lastly, the long-term failure mechanisms through flaw development for these synthetic hydrogel systems and biological tissue will be explored.
Item Open Access Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).(Contemporary clinical trials, 2019-01) Shelby, Rebecca A; Dorfman, Caroline S; Bosworth, Hayden B; Keefe, Francis; Sutton, Linda; Owen, Lynda; Corsino, Leonor; Erkanli, Alaattin; Reed, Shelby D; Arthur, Sarah S; Somers, Tamara; Barrett, Nadine; Huettel, Scott; Gonzalez, Juan Marcos; Kimmick, GretchenAdjuvant endocrine therapy (AET) is used to prevent recurrence and reduce mortality for women with hormone receptor positive breast cancer. Poor adherence to AET is a significant problem and contributes to increased medical costs and mortality. A variety of problematic symptoms associated with AET are related to non-adherence and early discontinuation of treatment. The goal of this study is to test a novel, telephone-based coping skills training that teaches patients adherence skills and techniques for coping with problematic symptoms (CST-AET). Adherence to AET will be assessed in real-time for 18 months using wireless smart pill bottles. Symptom interference (i.e., pain, vasomotor symptoms, sleep problems, vaginal dryness) and cost-effectiveness of the intervention protocol will be examined as secondary outcomes. Participants (N = 400) will be recruited from a tertiary care medical center or community clinics in medically underserved or rural areas. Participants will be randomized to receive CST-AET or a general health education intervention (comparison condition). CST-AET includes ten nurse-delivered calls delivered over 6 months. CST-AET provides systematic training in coping skills for managing symptoms that interfere with adherence. Interactive voice messaging provides reinforcement for skills use and adherence that is tailored based on real-time adherence data from the wireless smart pill bottles. Given the high rates of non-adherence and recent recommendations that women remain on AET for 10 years, we describe a timely trial. If effective, the CST-AET protocol may not only reduce the burden of AET use but also lead to cost-effective changes in clinical care and improve breast cancer outcomes. Trials registration: ClinicalTrials.gov, NCT02707471, registered 3/3/2016.Item Open Access The Experience and Self-Management of Fatigue in Adult Hemodialysis Patients(2012) Horigan, AnnFatigue is a common and debilitating symptom for adult patients with end-stage renal disease on hemodialysis and has been associated with decreased survival and quality of life. Patients on hemodialysis must find ways to manage their fatigue and mitigate its effects on their lives. Currently, there is no description of the experience of fatigue for American hemodialysis patients, nor is there any description of the ways in which they manage their fatigue. The purpose of this qualitative descriptive work was to describe the experience and self-management of fatigue as well as how fatigue changes over time from one dialysis session to the next. Several themes were identified which included: the nature of fatigue, cycles of fatigue, management of fatigue, consequences of fatigue, and correlates of fatigue. Further, hemodialysis patients experience two types of fatigue, post-dialysis fatigue, fatigue that occurs acutely after the dialysis session and resolves after sleep or rest, and constant fatigue, a persistent, underlying fatigue that patients experience at all times and worsens after the dialysis session usually requiring a prolonged period of recovery.
Item Open Access Understanding the Lexicon of Fatigue in Parkinson's Disease.(Journal of Parkinson's disease, 2020-06-15) Mantri, Sneha; Klawson, Emily; Albert, Steven; Nabieva, Karina; Lepore, Madeline; Kahl, Stephen; Daeschler, Margaret; Mamikonyan, Eugenia; Kopil, Catherine; Marras, Connie; Chahine, Lana MBACKGROUND:Fatigue in Parkinson's disease (PD) is multifaceted and associated with reduced quality of life. In turn, the language used by people with PD to describe fatigue is variable and poorly understood. We sought to elucidate the lexicon of fatigue using a qualitative grounded theory approach. OBJECTIVE:The objective of this study was to understand how patients with PD describe fatigue. METHODS:A pre-study phase of online journaling (Phase 1) provided information regarding topics of importance to patients. Following this, two independent samples of fatigued subjects were studied. Individuals with PD participated in a telephone interview (Phase 2); interview transcripts were analyzed to develop a detailed codebook. To ensure trustworthiness of the findings, an online survey (Phase 3) was administered to individuals with self-reported PD participating in the online study Fox Insight. The survey included the following question: "How do you define fatigue? Please provide your definition in the space below." The codebook developed from Phase 2 was applied to the Phase 3 responses. RESULTS:Fifteen individuals participated in Phase 2 and 413 individuals completed Phase 3. Fatigue was subdivided into three domains: cognitive, emotional, and physical. Nearly all individuals experienced more than one domain of fatigue. The most common themes included tiredness, lack of energy, and negative motivation. CONCLUSION:Fatigue in PD is multidimensional. Questionnaires that only assess the physical impact of fatigue may not be adequate to capture the broad range of experiences of fatigue among people with PD.